Trials / Sponsors / Oak Hill Bio Ltd
Oak Hill Bio Ltd
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely P Retinopathy of Prematurity (ROP), Intraventricular Hemorrhage, Bronchopulmonary Dysplasia | — | 2020-09-09 |
| Available | Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome Angelman Syndrome | — | — |